MDM2 and breast cancer: If so, however, Numb− BC PDXs might help in identifying the minimal efficacious dose of Nutlin‐3, or of other anti‐Mdm2 compounds, to obtain efficient anti‐CSC targeting, while reducing general toxicity: a possibility that warrants further investigations.